Bone tumors, particularly malignant bone tumors, pose a serious threat to human health, and their treatment has always been a clinical challenge. In recent years, with the rapid development of molecular biology, genomics, and immunology, breakthroughs have been made in bone tumor research. Biological regulation therapy and precision therapy, as emerging treatment strategies, have brought new hope to patients with bone tumors. 

This special issue aims to compile the latest research findings, explore cutting-edge hot topics and promote academic exchange and collaboration. We welcome everyone report on the latest advancements in the field of biological regulation and precision therapy for bone tumors, covering basic research, translational medicine, and clinical trials. We are keen on delving into the molecular mechanisms of bone tumor development, biomarkers, targeted therapy, immunotherapy, and others. We also expect provide a high-level academic exchange platform for experts and scholars in the field of bone tumor research worldwide, fostering collaboration and advancing the field.

We welcome a diversity of articles, such as conceptual and empirical articles, reviews, critical comments, and meta-analyses, for submission to this Special Issue. We will accept manuscripts from different disciplines, addressing topics related to the scope.

Bone Tumors

Biological Regulation

Precision Therapy

Targeted Therapy

Immunotherapy

Biomarkers

Molecular Mechanisms

Clinical Trials